Characteristics, Treatment, and Safety Profile of Patients With Atopic Dermatitis According to Eligibility for Randomized Clinical Trials: An Analysis From the Spanish Atopic Dermatitis Registry (BIOBADATOP)

Overall, 18.3% of real-world patients with AD-and 37.2% including those with EASI<16-are underrepresented in RCTs. Age and comorbidities influence safety outcomes and should be considered when taking treatment decisions and designing RCTs.

Authors

Institutions

Publication Details

Journal
Actas Dermo-Sifiliográficas
Published
2025-12-03
DOI
https://doi.org/10.1016/j.ad.2025.104489
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characteristics, Treatment, and Safety Profile of Patients With Atopic Dermatitis According to Eligibility for Randomized Clinical Trials: An Analysis From the Spanish Atopic Dermatitis Registry (BIOBADATOP)

Salvador Arias‐Santiago, Jorge Sánchez, Marta Bertolín‐Colilla, Trinidad Montero‐Vílchez et al.
Actas Dermo-Sifiliográficas
Dermatology and Skin Diseases
article

Characteristics, Treatment, and Safety Profile of Patients With Atopic Dermatitis According to Eligibility for Randomized Clinical Trials: An Analysis From the Spanish Atopic Dermatitis Registry (BIOBADATOP)

Salvador Arias‐Santiago, Jorge Sánchez, Marta Bertolín‐Colilla, Trinidad Montero‐Vílchez, Yolanda Gilaberte, Ricardo Ruíz‐Villaverde, Raquel Sanabria-de la Torre, A. Navarro Bielsa, Laia Curto‐Barredo, Inmaculada Bautista-Castaño, M. Rodríguez‐Serna, Isabel Betlloch, M.Á. Descalzo, F.J. Navarro‐Triviño, Pablo Chicharro, I. García‐Doval, M. Elosua-González, A M Giménez Arnau, J.F. Silvestre, J Rodríguez, Ana Batalla, Sandra Martínez‐Fernández, Miguel Antonio Lasheras‐Pérez, Alicia González Quesada, M Munera-Campos, J M Carrascosa Carrillo, JM Carrascosa, G. Roustán Gullón, Milena Arias, C. Couselo-Rodríguez, P de la Cueva Dovao
article en

Abstract

Overall, 18.3% of real-world patients with AD-and 37.2% including those with EASI<16-are underrepresented in RCTs. Age and comorbidities influence safety outcomes and should be considered when taking treatment decisions and designing RCTs.

Actas Dermo-SifiliográficasVol. 117(1)
Universitat Autònoma de Barcelona (ES), University Hospital Complex Of Vigo (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario de Gran Canaria Doctor Negrín (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Instituto de Investigación Biosanitaria de Granada (ES), Hospital Universitario Miguel Servet (ES), Hospital Universitario Virgen de las Nieves (ES), Hospital Universitario de La Princesa (ES), Hospital Del Mar (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Hospital Universitario Virgen del Rocío (ES), Hospital Universitari Germans Trias i Pujol (ES), Complejo Hospitalario de Pontevedra (ES), Hospital Universitario Infanta Leonor (ES)
Openalex Percentile: Top 39%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.